Bloomberg Anywhere Remote Login Bloomberg Terminal Request a Demo


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000


Industry Products

Media Services

Follow Us

September 05, 2015 1:50 AM ET


Company Overview of Synageva BioPharma Corp.

Executive Profile

Sanj K. Patel

Chief Executive Officer, President and Secretary, Synageva BioPharma Corp.
AgeTotal Calculated CompensationThis person is connected to 1 Board Members in 1 different organizations across 2 different industries.

See Board Relationships
As of Fiscal Year 2014


Mr. Sanj K. Patel has been the President and Chief Executive Officer of Synageva BioPharma Corp. since June 2008 and serves as its Secretary. Mr. Patel has 18 years of experience in the pharmaceutical and biotech industries. He joined Synageva from Genzyme Corporation from 1999 to 2008, where most recently, he served as the Head of US Sales, Marketing and Commercial Operations for Genzyme Therapeutics and led the commercial US launch for Myozyme®. Previously, he held ...

Corporate Headquarters

33 Hayden Avenue
Lexington, Massachusetts 02421

United States

Phone: 781-357-9900
Fax: 781-357-9901

Board Members Memberships

Director and Member of Compensation Committee


King's College
London South Bank University
Master's Degree
Ealing, Hammersmith and West London College

Other Affiliations

Annual Compensation

Total Annual Compensation$631,176

Stocks Options

All Other Compensation$11,950
Exercised Options$152,300
Exercised Options Value$12,677,365
Exercisable Options$245,932
Exercisable Options Value$14,931,054
Unexercisable Options$308,632
Unexercisable Options Value$12,526,993
Total Value of Options$40,135,412
Total Number of Options$706,864

Total Compensation

Total Annual Cash Compensation$1,040,767
Total Short Term Compensation$631,176
Other Long Term Compensation$11,950
Total Calculated Compensation$7,069,567

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup


There is no Competitor Compensation data available.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact Synageva BioPharma Corp., please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at